These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 28879549

  • 1. Decreased platelet count in children with epilepsy treated with valproate and its relationship to the immature platelet fraction.
    Kurahashi H, Takami A, Murotani K, Numoto S, Okumura A.
    Int J Hematol; 2018 Jan; 107(1):105-111. PubMed ID: 28879549
    [Abstract] [Full Text] [Related]

  • 2. Valproate-induced thrombocytopenia: a prospective monotherapy study.
    Nasreddine W, Beydoun A.
    Epilepsia; 2008 Mar; 49(3):438-45. PubMed ID: 18031547
    [Abstract] [Full Text] [Related]

  • 3. Valproate-associated coagulopathies are frequent and variable in children.
    Attilakos A, Katsarou E, Voudris K, Garoufi A.
    Epilepsia; 2007 Jan; 48(1):205-6. PubMed ID: 17241231
    [No Abstract] [Full Text] [Related]

  • 4. The effect of valproate therapy on thrombin generation determined by calibrated automated thrombography.
    Topf HG, Lischetzki G, Trollmann R, Rascher W, Rauh M.
    Klin Padiatr; 2011 May; 223(3):165-8. PubMed ID: 21472635
    [Abstract] [Full Text] [Related]

  • 5. Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?
    Lackmann GM.
    Pharmacology; 2004 Feb; 70(2):57-8. PubMed ID: 14685007
    [Abstract] [Full Text] [Related]

  • 6. Serum copper and zinc levels in epileptic children with valproate treatment.
    Kaji M, Ito M, Okuno T, Momoi T, Sasaki H, Yamanaka C, Yorifuji T, Mikawa H.
    Epilepsia; 1992 Feb; 33(3):555-7. PubMed ID: 1592036
    [Abstract] [Full Text] [Related]

  • 7. Effects of valproate on acylcarnitines in children with epilepsy using ESI-MS/MS.
    Werner T, Treiss I, Kohlmueller D, Mehlem P, Teich M, Longin E, Gerstner T, Koenig SA, Schulze A.
    Epilepsia; 2007 Jan; 48(1):72-6. PubMed ID: 17241210
    [Abstract] [Full Text] [Related]

  • 8. Severe, isolated thrombocytopenia under polytherapy with carbamazepine and valproate.
    Finsterer J, Pelzl G, Hess B.
    Psychiatry Clin Neurosci; 2001 Aug; 55(4):423-6. PubMed ID: 11442896
    [Abstract] [Full Text] [Related]

  • 9. Valproic acid and thrombocytopenia in children: a case-controlled retrospective study.
    Allarakhia IN, Garofalo EA, Komarynski MA, Robertson PL.
    Pediatr Neurol; 1996 May; 14(4):303-7. PubMed ID: 8805173
    [Abstract] [Full Text] [Related]

  • 10. The effects of valproate and topiramate use on serum insulin, leptin, neuropeptide Y and ghrelin levels in epileptic children.
    Çiçek NP, Kamaşak T, Serin M, Okten A, Alver A, Cansu A.
    Seizure; 2018 May; 58():90-95. PubMed ID: 29679911
    [Abstract] [Full Text] [Related]

  • 11. Valproate-associated coagulopathies are frequent and variable in children.
    Gerstner T, Teich M, Bell N, Longin E, Dempfle CE, Brand J, König S.
    Epilepsia; 2006 Jul; 47(7):1136-43. PubMed ID: 16886976
    [Abstract] [Full Text] [Related]

  • 12. Protein C, protein S and other pro- and anticoagulant activities among epileptic children using sodium valproate.
    Ugras M, Yakinci C.
    Brain Dev; 2006 Oct; 28(9):549-53. PubMed ID: 16842952
    [Abstract] [Full Text] [Related]

  • 13. Potential effects of valproate and oxcarbazepine on growth velocity and bone metabolism in epileptic children- a medical center experience.
    Lin CM, Fan HC, Chao TY, Chu DM, Lai CC, Wang CC, Chen SJ.
    BMC Pediatr; 2016 May 03; 16():61. PubMed ID: 27142370
    [Abstract] [Full Text] [Related]

  • 14. Valproic acid and immune thrombocytopenia.
    Barr RD, Copeland SA, Stockwell ML, Morris N, Kelton JC.
    Arch Dis Child; 1982 Sep 03; 57(9):681-4. PubMed ID: 6812506
    [Abstract] [Full Text] [Related]

  • 15. Valproic acid and thrombocytopenia: cross-sectional study.
    Ko CH, Kong CK, Tse PW.
    Hong Kong Med J; 2001 Mar 03; 7(1):15-21. PubMed ID: 11406671
    [Abstract] [Full Text] [Related]

  • 16. Influence of valproate monotherapy on platelet activation and hematologic values.
    Zeller JA, Schlesinger S, Runge U, Kessler C.
    Epilepsia; 1999 Feb 03; 40(2):186-9. PubMed ID: 9952265
    [Abstract] [Full Text] [Related]

  • 17. Thrombocytopenia secondary to high valproate levels in children with epilepsy.
    Delgado MR, Riela AR, Mills J, Browne R, Roach ES.
    J Child Neurol; 1994 Jul 03; 9(3):311-4. PubMed ID: 7930412
    [Abstract] [Full Text] [Related]

  • 18. Subclinical hypothyroidism during valproic acid therapy in children and adolescents with epilepsy.
    Kim SH, Chung HR, Kim SH, Kim H, Lim BC, Chae JH, Kim KJ, Hwang YS, Hwang H.
    Neuropediatrics; 2012 Jun 03; 43(3):135-9. PubMed ID: 22618302
    [Abstract] [Full Text] [Related]

  • 19. Determinants of free serum valproate concentration: A prospective study in patients on divalproex sodium monotherapy.
    Nasreddine W, Dirani M, Atweh S, Makki A, Beydoun A.
    Seizure; 2018 Jul 03; 59():24-27. PubMed ID: 29730272
    [Abstract] [Full Text] [Related]

  • 20. Hematologic manifestations and impaired liver synthetic function during valproate monotherapy.
    Hauser E, Seidl R, Freilinger M, Male C, Herkner K.
    Brain Dev; 1996 Jul 03; 18(2):105-9. PubMed ID: 8733899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.